(Q39473882)

12 September 2017

Comparative killing rates of fluoroquinolones and cell wall-active agents (English)

1 reference

12 September 2017

1 reference

J C Fung-Tomc

1

1 reference

12 September 2017

E Gradelski

2

1 reference

12 September 2017

L Valera

3

1 reference

12 September 2017

B Kolek

4

1 reference

12 September 2017

D P Bonner

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

44

1 reference

12 September 2017

5

1 reference

12 September 2017

1377-1380

1 reference

Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Bactericidal activity of trovafloxacin (CP-99,219).

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Antibacterial activity of a 1,8-naphthyridine quinolone, PD131628

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

Bactericidal properties of moxifloxacin and post-antibiotic effect.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89877

In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics

21 August 2018

1 reference

12 December 2020

The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis

1 reference

12 December 2020

Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents

1 reference

12 December 2020

Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

1 reference

12 December 2020

10.1128/AAC.44.5.1377-1380.2000

Identifiers

DOI

1 reference

release_6hgezskp75behhzaoupcgizfnm

12 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6hgezskp75behhzaoupcgizfnm

24 November 2022

mapped directly with Wikidata item

1 reference

12 September 2017

PubMed publication ID

10770784

1 reference